Press release content from Business Wire. The AP news staff was not involved in its creation.
Agilent Names Allison Ballmer Senior Vice President of Strategy and Corporate Development
January 15, 2021 GMT
SANTA CLARA, Calif. (BUSINESS WIRE) Jan 15, 2021
Agilent Technologies Inc.(NYSE: A) is pleased to announce Allison Ballmer has been named the company’s new senior vice president of Strategy and Corporate Development, reporting to Agilent President and CEO Mike McMullen.
Ballmer will lead the corporate development team in identifying, developing, and evaluating merger-and-acquisition plans globally, as well as program management of integrations. She also will lead enterprise strategy while collaborating with Agilent businesses groups to drive critical growth initiatives across the company. Ballmer will serve as a key member of the executive staff and as an adviser to the CEO to help shape the company’s overall strategic direction.
Share this article
Share this article
FREMONT, Calif., Jan. 13, 2021 /PRNewswire/ The premium market intelligence report published by BIS Research on the title Global MRD Testing Market highlights that the market is projected to reach $1.61 billion by 2025. The study also highlights that the market is set to witness a CAGR of 15.64% during the period between 2020 and 2025. The growth is aided by factors including increasing research funding from the National Cancer Institute and rising incidence of hematologic malignancies, among others.
Minimal residual disease (MRD) testing is an evolving testing regimen that has been driving initiatives in the management of hematological malignancy patients. It is currently one of the fastest-growing markets under the molecular diagnostics umbrella. MRD testing promises the integration of evolutionary molecular technologies into hematological malignancy care regimens, thereby driving tremendous growth in the overall hematological malignanc
Share this article
Share this article
ResearchAndMarkets.com s offering.
The Single-cell Sequencing Services and Technologies Market, 2020-2030 report features an extensive study of the current landscape and the future opportunities associated with single-cell sequencing services/technologies.
One of the key objectives of the report was to understand the primary growth drivers and estimate the future opportunity within the market. Based on several parameters, such as number of single-cell samples sequenced annually, average cost of sequencing, and growth trends across various geographies, we have provided an informed estimate of the likely evolution of the market, in the mid to long term, for the period 2020-2030.
Vizgen Launches With $14M Series A Financing
SeqWell Raises $9M in Series B Round
MGI Tech Introduces Portable Sequencer, Single-Cell Prep Device
Celsius Therapeutics to Use Single-Cell Platform in Immuno-Oncology
Genomics Expects $271M In Proceeds
Celsius Therapeutics, Janssen Biotech Form Biomarker Discovery Alliance
Bio-Rad, 10x Genomics Claim Single-Cell Patent Fight Victories on Different Fronts
Bio-Rad Launches its Single Cell scATAC-Seq Solution
Genomics Acquires Spatial Transcriptomics
Mission Bio Launches Tapestri for Targeted Single-Cell DNA Custom Panels
SingulOmics Detects Somatic Single Nucleotide Variations in Single Cells
1CELLBIO and OMI to validate Single Cell Analysis for Personalized Medicine
Sony MA900 Cell Sorter Nominated
PM360 Announces The Selections For Its 9th Annual Innovations Issue
The healthcare industry s most innovative companies, startups, divisions, products, services, and strategies of 2020
News provided by
Share this article
Share this article
NEW YORK, Dec. 10, 2020 /PRNewswire/ One of the things the COVID-19 global pandemic has helped to illustrate is the incredible importance of the life sciences industry s ability to innovate. While every industry can claim innovation as the lifeblood of its success, for the life sciences industry innovation often means helping to save lives or improving the quality of people s lives as they deal with diseases.
PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has long recognized how crucial innovation is within this industry and nine years ago established the first-ever guide to highlight the past year s most impressive or interesting innovations.